Expert Interview
Discussing dermatomyositis and the potential of JAK inhibitors with a focus on brepocitinib
Ticker(s): ROIVInstitution: University of Manchester
- Professor of Rheumatology and Neuromuscular Disease at The University of Manchester, UK
- Has research interests in genetic, epidemiological and clinical aspects of adult idiopathic inflammatory myopathy
- Principal investigator of a UK Medical Research Council funded prospective myositis cohort collection called MYOPROSP. At Salford Royal, he runs general rheumatology, adult neuromuscular and combined psoriasis/psoriatic clinics.
how many DM patients do you manage?
Added By: wilson_adminHow are they currently treated?
Added By: wilson_adminWhat would you need to see for brepocitinib to supplant the current standard of care?
Added By: wilson_adminAre You Interested In These Questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
